chartexchange

NTLA
Intellia Therapeutics, Inc
stockNASDAQ

Market OpenNov 19, 2026 3:20:41 PM EST
9.21USD-5.732%(-0.56)4,915,071
Pre-marketNov 19, 2026 9:29:30 AM EST
9.91USD+1.433%(+0.14)
9.2000Bid9.2100Ask0.0100Spread

NTLA Financials

In Q3 FY 2026 (ended ), Intellia Therapeutics, Inc (NTLA) reported revenue of $7.16M, net income of −$127.49M, operating cash flow of −$85.43M, and assets of $902.56M (filed ).

Loading financial statements…